Cancer Institute A national cancer institute
designated cancer center

Department: Stanford Cancer Institute

Molecular Profiling

  • Keith and Jan Hurlbut Professor in the Stanford University School of Medicine
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Urologic Oncology
    • Male Cancers - Prostate
    • Prostate Cancer
    Research Interest

    We use genomic approaches to identify disease biomarkers. We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer.

  • Professor of Biochemistry
    Member, Stanford Cancer Institute
    Research Interest

    Dr. Brown's research group uses diverse experimental and computational methods to investigate the logic and mechanisms that control a genome's expression program. The Brown laboratory is systematically characterizing the genetic scripts that control the expression of our genes, in normal development and physiology and in diseases like cancer, with a particular focus on post-transcriptional regulation. The Brown lab also develops strategies and assays for early detection and diagnosis of cancer.

  • Professor of Medicine (Oncology) and of Biochemistry
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Clinical Focus
    • GI Oncology
    • Oncology
    Research Interest

    Our laboratory focuses on understanding how cells respond to DNA damage. Our research currently involves areas that interact with each other: repair of radiation damage, and transcriptional responses to DNA damage.

  • Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Clinical Focus
    • Pediatric Hematology-Oncology
    • Ped Hematology/Oncology
    Research Interest

    Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.

  • Max H. Stein Professor and Professor of Statistics and of Health Research and Policy
    Member, Stanford Cancer Institute
    Research Interest

    Theories of inference applied to biostatistical data;, the bootstrap method.

  • Associate Professor of Biochemistry
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Research Interest

    Our lab engineers proteins and small-molecule drugs at atomic resolution through a combination of structural calculations and combinatorial library synthesis. Our goal is to elucidate predictive principles by which novel shapes and catalytic properties can be conferred accurately on designed polypeptides.

  • John A. Overdeck Professor and Professor of Health Research and Policy
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Flexible statistical modelling, datamining, bioinformatics, and statistical computing.

  • Senior Associate Dean, Graduate Education and Postdoctoral Affairs and Professor of Biochemistry and, by courtesy, of Chemistry and of Chemical Engineering
    Member, Bio-X
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Research Interest

    Our research is aimed at understanding the chemical and physical behavior underlying biological macromolecules and systems, as these behaviors define the capabilities and limitations of biology. Toward this end we study folding and catalysis by RNA, as well as catalysis by protein enzymes.

  • John and Marva Warnock Professor
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Breast Cancer
    • General Surgery
    Research Interest

    Dr. Jeffrey led the multidisciplinary team from the Schools of Medicine, Engineering, and Genome Technology Center that invented the MagSweeper, an automated device that immunomagnetically captures live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis or culture. Her lab also works on microfluidic technologies for tumor cell capture, characterization, and growth - with the goal of defining individual patient response to newer biologically-based cancer therapies.

  • Professor of Pathology at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Anatomic/Clinical Pathology
    • Pathology and Laboratory Medicine
    Research Interest

    Gynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.

  • Associate Professor of Medicine (Gastroenterology and Hepatology)
    Member, Stanford Cancer Institute
    Clinical Focus
    • Gastroenterology
    • Pancreatic diseases
    • Gastrointestinal Cancers
    Research Interest

    Our laboratory is focused on adenocarcinomas, which account for the majority of human solid tumors that result in death. Active projects include pancreatic, esophageal, colon, and lung adenocarcinomas. We have a particular interest in the regulation of signal transduction with respect to wound healing and cancer development. Active projects not only include cancer pathogenesis, but also the development of new diagnostic assays and drugs.

  • Associate Professor of Medicine (Hematology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Hematology
    • Hematology
    • Acute leukemia
    Research Interest

    My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.

  • Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Thoracic Oncology
    • Thoracic Oncology
    • Lung Cancer
    Research Interest

    Applying new technologies to the diagnosis, characterization, and treatment of non-small cell lung cancer.

  • Associate Professor of Pathology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Our laboratory uses genomic approaches to explore patterns of gene expression and gene copy number alteration in human cancer cell line model systems and in tumors, with the goals of better understanding cancer, and developing novel diagnostic and therapeutic strategies.

  • Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
    Member, Bio-X
    Senior Fellow, Center for International Security and Cooperation
    Member, Stanford Cancer Institute
    Clinical Focus
    • Infectious Disease
    Research Interest

    My investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Allan and Tina Neill Professor of Lymphatic Research and Medicine
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphatic Diseases
    • Cardiology (Heart)
    • Cardiology (Heart), Preventive
    Research Interest

    My clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.

  • Associate Professor of Genetics
    Member, Stanford Cancer Institute
    Research Interest

    Evolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species

  • Douglass M. and Nola Leishman Professor of Cardiovascular Disease
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Research Interest

    The general research interest of this laboratory is the molecular basis of cell motility. We have three specific research interests, the molecular basis of energy transduction that leads to ATP-driven myosin movement on actin, the biochemical basis of the regulation of actin and myosin interaction and their assembly states, and the roles these proteins play in vivo, in cell movement and changes in cell shape.

Stanford Medicine Resources:

Footer Links: